← Leaderboards
Aram F Hezel
Massachusetts General Hospital
$2,295,490
Attributed
$2,295,490
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $318.5K · FY2006–17$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,295,490 · 2
By mechanism
R01$1,583,010 · 1
K08$712,480 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Xandra Owens Breakefield$30,735,276
- Daniel A. Haber$29,412,047
- Nicholas J Dyson$20,553,237
- Nabeel Bardeesy$18,920,034
- Vijaya Ramesh$9,458,883
Others in their field
Top investigators on “Genetically Engineered Mouse”
- Martin Ringwald · Jackson Laboratory$31,084,352
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$26,234,170
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$25,747,924
- David H Perlmutter · Washington University$25,600,757
- Karl Alexander Deisseroth · Stanford University$25,421,367
- Wesley Ian Sundquist · Utah State Higher Education System--University Of Utah$24,664,596
Research focus
Genetically Engineered MouseHuman DiseaseLesionTumorOncogenicMolecularGeneticInvestigationMutantResponseTumor ProgressionBiological ModelsMutationMouse ModelEventGenesTp53 GeneCatabolismCancer TypeAutophagocytosisBiologyCholangiocarcinomaAffectDisease Model
Grant awards (10)
Genetics pathways in intra-hepatic cholangiocarcinoma$318,513
R01 · FY2017 · CA · contact PI
Genetics pathways in intra-hepatic cholangiocarcinoma$318,513
R01 · FY2016 · CA · contact PI
Genetics pathways in intra-hepatic cholangiocarcinoma$318,513
R01 · FY2015 · CA · contact PI
Genetics pathways in intra-hepatic cholangiocarcinoma$308,958
R01 · FY2014 · CA · contact PI
Genetics pathways in intra-hepatic cholangiocarcinoma$318,513
R01 · FY2013 · CA · contact PI
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer$144,180
K08 · FY2010 · CA · contact PI
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer$143,370
K08 · FY2009 · CA · contact PI
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer$142,560
K08 · FY2008 · CA · contact PI
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer$141,750
K08 · FY2007 · CA · contact PI
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer$140,620
K08 · FY2006 · CA · contact PI